nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitisinone—Septicemia—Methotrexate—systemic scleroderma	0.0164	0.0164	CcSEcCtD
Nitisinone—Cataract—Mometasone—systemic scleroderma	0.0127	0.0127	CcSEcCtD
Nitisinone—Neoplasm malignant—Azathioprine—systemic scleroderma	0.0108	0.0108	CcSEcCtD
Nitisinone—Blepharitis—Mycophenolate mofetil—systemic scleroderma	0.0107	0.0107	CcSEcCtD
Nitisinone—Thirst—Pentoxifylline—systemic scleroderma	0.0106	0.0106	CcSEcCtD
Nitisinone—Encephalopathy—Mycophenolate mofetil—systemic scleroderma	0.0102	0.0102	CcSEcCtD
Nitisinone—Keratitis—Mycophenolate mofetil—systemic scleroderma	0.0101	0.0101	CcSEcCtD
Nitisinone—Gastroenteritis—Mometasone—systemic scleroderma	0.00987	0.00987	CcSEcCtD
Nitisinone—Neoplasm malignant—Mycophenolic acid—systemic scleroderma	0.00974	0.00974	CcSEcCtD
Nitisinone—Cyanosis—Mycophenolate mofetil—systemic scleroderma	0.00928	0.00928	CcSEcCtD
Nitisinone—Cataract—Leflunomide—systemic scleroderma	0.00916	0.00916	CcSEcCtD
Nitisinone—Leukocytosis—Mycophenolic acid—systemic scleroderma	0.00885	0.00885	CcSEcCtD
Nitisinone—Cataract—Mycophenolic acid—systemic scleroderma	0.00874	0.00874	CcSEcCtD
Nitisinone—Melaena—Leflunomide—systemic scleroderma	0.00852	0.00852	CcSEcCtD
Nitisinone—Respiratory failure—Mycophenolic acid—systemic scleroderma	0.00847	0.00847	CcSEcCtD
Nitisinone—Dermatitis exfoliative—Captopril—systemic scleroderma	0.00814	0.00814	CcSEcCtD
Nitisinone—Melaena—Mycophenolic acid—systemic scleroderma	0.00813	0.00813	CcSEcCtD
Nitisinone—Leukocytosis—Lisinopril—systemic scleroderma	0.00797	0.00797	CcSEcCtD
Nitisinone—Rash maculo-papular—Leflunomide—systemic scleroderma	0.00793	0.00793	CcSEcCtD
Nitisinone—Hepatic function abnormal—Azathioprine—systemic scleroderma	0.00767	0.00767	CcSEcCtD
Nitisinone—Conjunctivitis—Pentoxifylline—systemic scleroderma	0.00759	0.00759	CcSEcCtD
Nitisinone—Sepsis—Leflunomide—systemic scleroderma	0.00757	0.00757	CcSEcCtD
Nitisinone—Amenorrhoea—Mycophenolate mofetil—systemic scleroderma	0.00747	0.00747	CcSEcCtD
Nitisinone—Hepatic failure—Azathioprine—systemic scleroderma	0.00746	0.00746	CcSEcCtD
Nitisinone—Epistaxis—Pentoxifylline—systemic scleroderma	0.00737	0.00737	CcSEcCtD
Nitisinone—Bronchitis—Mometasone—systemic scleroderma	0.00727	0.00727	CcSEcCtD
Nitisinone—Sepsis—Mycophenolic acid—systemic scleroderma	0.00722	0.00722	CcSEcCtD
Nitisinone—Gastroenteritis—Leflunomide—systemic scleroderma	0.00714	0.00714	CcSEcCtD
Nitisinone—Haemoglobin—Pentoxifylline—systemic scleroderma	0.00705	0.00705	CcSEcCtD
Nitisinone—Hepatic failure—Leflunomide—systemic scleroderma	0.00704	0.00704	CcSEcCtD
Nitisinone—Photophobia—Lisinopril—systemic scleroderma	0.00703	0.00703	CcSEcCtD
Nitisinone—Haemorrhage—Pentoxifylline—systemic scleroderma	0.00701	0.00701	CcSEcCtD
Nitisinone—Leukocytosis—Mycophenolate mofetil—systemic scleroderma	0.00699	0.00699	CcSEcCtD
Nitisinone—Cataract—Mycophenolate mofetil—systemic scleroderma	0.0069	0.0069	CcSEcCtD
Nitisinone—Gastroenteritis—Mycophenolic acid—systemic scleroderma	0.00681	0.00681	CcSEcCtD
Nitisinone—Respiratory failure—Mycophenolate mofetil—systemic scleroderma	0.00669	0.00669	CcSEcCtD
Nitisinone—Conjunctivitis—Mometasone—systemic scleroderma	0.00655	0.00655	CcSEcCtD
Nitisinone—Melaena—Mycophenolate mofetil—systemic scleroderma	0.00641	0.00641	CcSEcCtD
Nitisinone—Epistaxis—Mometasone—systemic scleroderma	0.00636	0.00636	CcSEcCtD
Nitisinone—Thirst—Mycophenolic acid—systemic scleroderma	0.00635	0.00635	CcSEcCtD
Nitisinone—Hepatomegaly—Prednisone—systemic scleroderma	0.00629	0.00629	CcSEcCtD
Nitisinone—Hepatic function abnormal—Lisinopril—systemic scleroderma	0.00622	0.00622	CcSEcCtD
Nitisinone—Hypoglycaemia—Mycophenolic acid—systemic scleroderma	0.00619	0.00619	CcSEcCtD
Nitisinone—Photophobia—Mycophenolate mofetil—systemic scleroderma	0.00616	0.00616	CcSEcCtD
Nitisinone—Gastroenteritis—Lisinopril—systemic scleroderma	0.00614	0.00614	CcSEcCtD
Nitisinone—Hepatic failure—Lisinopril—systemic scleroderma	0.00605	0.00605	CcSEcCtD
Nitisinone—Gastrointestinal haemorrhage—Mycophenolic acid—systemic scleroderma	0.00604	0.00604	CcSEcCtD
Nitisinone—Tension—Pentoxifylline—systemic scleroderma	0.00599	0.00599	CcSEcCtD
Nitisinone—Rash maculo-papular—Mycophenolate mofetil—systemic scleroderma	0.00597	0.00597	CcSEcCtD
Nitisinone—Nervousness—Pentoxifylline—systemic scleroderma	0.00593	0.00593	CcSEcCtD
Nitisinone—Dry skin—Leflunomide—systemic scleroderma	0.0058	0.0058	CcSEcCtD
Nitisinone—Encephalopathy—Methotrexate—systemic scleroderma	0.00579	0.00579	CcSEcCtD
Nitisinone—Hyperkinesia—Mycophenolate mofetil—systemic scleroderma	0.00573	0.00573	CcSEcCtD
Nitisinone—Sepsis—Mycophenolate mofetil—systemic scleroderma	0.0057	0.0057	CcSEcCtD
Nitisinone—Dehydration—Mycophenolic acid—systemic scleroderma	0.00562	0.00562	CcSEcCtD
Nitisinone—Agitation—Pentoxifylline—systemic scleroderma	0.00561	0.00561	CcSEcCtD
Nitisinone—Gastritis—Leflunomide—systemic scleroderma	0.0056	0.0056	CcSEcCtD
Nitisinone—Hypoglycaemia—Lisinopril—systemic scleroderma	0.00557	0.00557	CcSEcCtD
Nitisinone—Agranulocytosis—Captopril—systemic scleroderma	0.00552	0.00552	CcSEcCtD
Nitisinone—Leukopenia—Pentoxifylline—systemic scleroderma	0.00546	0.00546	CcSEcCtD
Nitisinone—Gastroenteritis—Mycophenolate mofetil—systemic scleroderma	0.00538	0.00538	CcSEcCtD
Nitisinone—Gastritis—Mycophenolic acid—systemic scleroderma	0.00534	0.00534	CcSEcCtD
Nitisinone—Hepatic failure—Mycophenolate mofetil—systemic scleroderma	0.0053	0.0053	CcSEcCtD
Nitisinone—Convulsion—Pentoxifylline—systemic scleroderma	0.00529	0.00529	CcSEcCtD
Nitisinone—Eye pain—Mycophenolate mofetil—systemic scleroderma	0.00528	0.00528	CcSEcCtD
Nitisinone—Bronchitis—Leflunomide—systemic scleroderma	0.00526	0.00526	CcSEcCtD
Nitisinone—Cyanosis—Methotrexate—systemic scleroderma	0.00525	0.00525	CcSEcCtD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—systemic scleroderma	0.00516	0.00516	CcSEcCtD
Nitisinone—Amenorrhoea—Prednisone—systemic scleroderma	0.00506	0.00506	CcSEcCtD
Nitisinone—Dehydration—Lisinopril—systemic scleroderma	0.00506	0.00506	CcSEcCtD
Nitisinone—Bronchitis—Mycophenolic acid—systemic scleroderma	0.00502	0.00502	CcSEcCtD
Nitisinone—Thirst—Mycophenolate mofetil—systemic scleroderma	0.00501	0.00501	CcSEcCtD
Nitisinone—Infection—Pentoxifylline—systemic scleroderma	0.00495	0.00495	CcSEcCtD
Nitisinone—Hypoglycaemia—Mycophenolate mofetil—systemic scleroderma	0.00488	0.00488	CcSEcCtD
Nitisinone—Thrombocytopenia—Pentoxifylline—systemic scleroderma	0.00488	0.00488	CcSEcCtD
Nitisinone—Skin disorder—Pentoxifylline—systemic scleroderma	0.00484	0.00484	CcSEcCtD
Nitisinone—Agranulocytosis—Azathioprine—systemic scleroderma	0.00482	0.00482	CcSEcCtD
Nitisinone—Gastritis—Lisinopril—systemic scleroderma	0.00481	0.00481	CcSEcCtD
Nitisinone—Gastrointestinal haemorrhage—Mycophenolate mofetil—systemic scleroderma	0.00477	0.00477	CcSEcCtD
Nitisinone—Conjunctivitis—Leflunomide—systemic scleroderma	0.00474	0.00474	CcSEcCtD
Nitisinone—Leukocytosis—Prednisone—systemic scleroderma	0.00474	0.00474	CcSEcCtD
Nitisinone—Alopecia—Captopril—systemic scleroderma	0.0047	0.0047	CcSEcCtD
Nitisinone—Cataract—Prednisone—systemic scleroderma	0.00467	0.00467	CcSEcCtD
Nitisinone—Haemoglobin—Azathioprine—systemic scleroderma	0.00466	0.00466	CcSEcCtD
Nitisinone—Haemorrhage—Azathioprine—systemic scleroderma	0.00464	0.00464	CcSEcCtD
Nitisinone—Epistaxis—Leflunomide—systemic scleroderma	0.0046	0.0046	CcSEcCtD
Nitisinone—Agranulocytosis—Leflunomide—systemic scleroderma	0.00455	0.00455	CcSEcCtD
Nitisinone—Tension—Captopril—systemic scleroderma	0.00454	0.00454	CcSEcCtD
Nitisinone—Conjunctivitis—Mycophenolic acid—systemic scleroderma	0.00452	0.00452	CcSEcCtD
Nitisinone—Bronchitis—Lisinopril—systemic scleroderma	0.00452	0.00452	CcSEcCtD
Nitisinone—Nervousness—Captopril—systemic scleroderma	0.00449	0.00449	CcSEcCtD
Nitisinone—Dehydration—Mycophenolate mofetil—systemic scleroderma	0.00443	0.00443	CcSEcCtD
Nitisinone—Somnolence—Pentoxifylline—systemic scleroderma	0.00443	0.00443	CcSEcCtD
Nitisinone—Haemoglobin—Leflunomide—systemic scleroderma	0.0044	0.0044	CcSEcCtD
Nitisinone—Epistaxis—Mycophenolic acid—systemic scleroderma	0.00439	0.00439	CcSEcCtD
Nitisinone—Haemorrhage—Leflunomide—systemic scleroderma	0.00438	0.00438	CcSEcCtD
Nitisinone—Agranulocytosis—Mycophenolic acid—systemic scleroderma	0.00434	0.00434	CcSEcCtD
Nitisinone—Infection—Mometasone—systemic scleroderma	0.00427	0.00427	CcSEcCtD
Nitisinone—Gastritis—Mycophenolate mofetil—systemic scleroderma	0.00422	0.00422	CcSEcCtD
Nitisinone—Haemoglobin—Mycophenolic acid—systemic scleroderma	0.0042	0.0042	CcSEcCtD
Nitisinone—Haemorrhage—Mycophenolic acid—systemic scleroderma	0.00418	0.00418	CcSEcCtD
Nitisinone—Alopecia—Azathioprine—systemic scleroderma	0.0041	0.0041	CcSEcCtD
Nitisinone—Eye disorder—Leflunomide—systemic scleroderma	0.00409	0.00409	CcSEcCtD
Nitisinone—Gastrointestinal pain—Pentoxifylline—systemic scleroderma	0.00407	0.00407	CcSEcCtD
Nitisinone—Bronchitis—Mycophenolate mofetil—systemic scleroderma	0.00396	0.00396	CcSEcCtD
Nitisinone—Epistaxis—Lisinopril—systemic scleroderma	0.00395	0.00395	CcSEcCtD
Nitisinone—Abdominal pain—Pentoxifylline—systemic scleroderma	0.00394	0.00394	CcSEcCtD
Nitisinone—Agranulocytosis—Lisinopril—systemic scleroderma	0.00391	0.00391	CcSEcCtD
Nitisinone—Eye disorder—Mycophenolic acid—systemic scleroderma	0.0039	0.0039	CcSEcCtD
Nitisinone—Hyperkinesia—Prednisone—systemic scleroderma	0.00388	0.00388	CcSEcCtD
Nitisinone—Alopecia—Leflunomide—systemic scleroderma	0.00387	0.00387	CcSEcCtD
Nitisinone—Sepsis—Prednisone—systemic scleroderma	0.00386	0.00386	CcSEcCtD
Nitisinone—Respiratory failure—Methotrexate—systemic scleroderma	0.00379	0.00379	CcSEcCtD
Nitisinone—Thrombocytopenia—Captopril—systemic scleroderma	0.0037	0.0037	CcSEcCtD
Nitisinone—Alopecia—Mycophenolic acid—systemic scleroderma	0.00369	0.00369	CcSEcCtD
Nitisinone—Melaena—Methotrexate—systemic scleroderma	0.00363	0.00363	CcSEcCtD
Nitisinone—Leukopenia—Azathioprine—systemic scleroderma	0.00361	0.00361	CcSEcCtD
Nitisinone—Conjunctivitis—Mycophenolate mofetil—systemic scleroderma	0.00357	0.00357	CcSEcCtD
Nitisinone—Tension—Mycophenolic acid—systemic scleroderma	0.00357	0.00357	CcSEcCtD
Nitisinone—Nervousness—Mycophenolic acid—systemic scleroderma	0.00353	0.00353	CcSEcCtD
Nitisinone—Pruritus—Pentoxifylline—systemic scleroderma	0.00352	0.00352	CcSEcCtD
Nitisinone—Gastrointestinal pain—Mometasone—systemic scleroderma	0.00351	0.00351	CcSEcCtD
Nitisinone—Epistaxis—Mycophenolate mofetil—systemic scleroderma	0.00346	0.00346	CcSEcCtD
Nitisinone—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.00343	0.00343	CcSEcCtD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic scleroderma	0.00341	0.00341	CcSEcCtD
Nitisinone—Leukopenia—Leflunomide—systemic scleroderma	0.00341	0.00341	CcSEcCtD
Nitisinone—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00341	0.00341	CcSEcCtD
Nitisinone—Abdominal pain—Mometasone—systemic scleroderma	0.0034	0.0034	CcSEcCtD
Nitisinone—Somnolence—Captopril—systemic scleroderma	0.00336	0.00336	CcSEcCtD
Nitisinone—Agitation—Mycophenolic acid—systemic scleroderma	0.00334	0.00334	CcSEcCtD
Nitisinone—Alopecia—Lisinopril—systemic scleroderma	0.00332	0.00332	CcSEcCtD
Nitisinone—Haemoglobin—Mycophenolate mofetil—systemic scleroderma	0.00331	0.00331	CcSEcCtD
Nitisinone—Haemorrhage—Mycophenolate mofetil—systemic scleroderma	0.0033	0.0033	CcSEcCtD
Nitisinone—Infection—Azathioprine—systemic scleroderma	0.00327	0.00327	CcSEcCtD
Nitisinone—Leukopenia—Mycophenolic acid—systemic scleroderma	0.00326	0.00326	CcSEcCtD
Nitisinone—Gastrointestinal haemorrhage—Prednisone—systemic scleroderma	0.00323	0.00323	CcSEcCtD
Nitisinone—Sepsis—Methotrexate—systemic scleroderma	0.00323	0.00323	CcSEcCtD
Nitisinone—Thrombocytopenia—Azathioprine—systemic scleroderma	0.00323	0.00323	CcSEcCtD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.00322	0.00322	CcSEcCtD
Nitisinone—Tension—Lisinopril—systemic scleroderma	0.00321	0.00321	CcSEcCtD
Nitisinone—Skin disorder—Azathioprine—systemic scleroderma	0.0032	0.0032	CcSEcCtD
Nitisinone—Nervousness—Lisinopril—systemic scleroderma	0.00318	0.00318	CcSEcCtD
Nitisinone—Convulsion—Mycophenolic acid—systemic scleroderma	0.00315	0.00315	CcSEcCtD
Nitisinone—Headache—Pentoxifylline—systemic scleroderma	0.00312	0.00312	CcSEcCtD
Nitisinone—Infection—Leflunomide—systemic scleroderma	0.00309	0.00309	CcSEcCtD
Nitisinone—Gastrointestinal pain—Captopril—systemic scleroderma	0.00309	0.00309	CcSEcCtD
Nitisinone—Eye disorder—Mycophenolate mofetil—systemic scleroderma	0.00308	0.00308	CcSEcCtD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.00307	0.00307	CcSEcCtD
Nitisinone—Thrombocytopenia—Leflunomide—systemic scleroderma	0.00305	0.00305	CcSEcCtD
Nitisinone—Pruritus—Mometasone—systemic scleroderma	0.00304	0.00304	CcSEcCtD
Nitisinone—Skin disorder—Leflunomide—systemic scleroderma	0.00302	0.00302	CcSEcCtD
Nitisinone—Hepatic failure—Methotrexate—systemic scleroderma	0.003	0.003	CcSEcCtD
Nitisinone—Abdominal pain—Captopril—systemic scleroderma	0.00298	0.00298	CcSEcCtD
Nitisinone—Dry skin—Prednisone—systemic scleroderma	0.00296	0.00296	CcSEcCtD
Nitisinone—Infection—Mycophenolic acid—systemic scleroderma	0.00295	0.00295	CcSEcCtD
Nitisinone—Diarrhoea—Mometasone—systemic scleroderma	0.00294	0.00294	CcSEcCtD
Nitisinone—Leukopenia—Lisinopril—systemic scleroderma	0.00293	0.00293	CcSEcCtD
Nitisinone—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.00291	0.00291	CcSEcCtD
Nitisinone—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.00291	0.00291	CcSEcCtD
Nitisinone—Skin disorder—Mycophenolic acid—systemic scleroderma	0.00288	0.00288	CcSEcCtD
Nitisinone—Dermatitis exfoliative—Methotrexate—systemic scleroderma	0.00286	0.00286	CcSEcCtD
Nitisinone—Tension—Mycophenolate mofetil—systemic scleroderma	0.00282	0.00282	CcSEcCtD
Nitisinone—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.00279	0.00279	CcSEcCtD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.00277	0.00277	CcSEcCtD
Nitisinone—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00269	0.00269	CcSEcCtD
Nitisinone—Headache—Mometasone—systemic scleroderma	0.00269	0.00269	CcSEcCtD
Nitisinone—Pruritus—Captopril—systemic scleroderma	0.00267	0.00267	CcSEcCtD
Nitisinone—Infection—Lisinopril—systemic scleroderma	0.00266	0.00266	CcSEcCtD
Nitisinone—Somnolence—Mycophenolic acid—systemic scleroderma	0.00264	0.00264	CcSEcCtD
Nitisinone—Agitation—Mycophenolate mofetil—systemic scleroderma	0.00264	0.00264	CcSEcCtD
Nitisinone—Thrombocytopenia—Lisinopril—systemic scleroderma	0.00262	0.00262	CcSEcCtD
Nitisinone—Abdominal pain—Azathioprine—systemic scleroderma	0.0026	0.0026	CcSEcCtD
Nitisinone—Skin disorder—Lisinopril—systemic scleroderma	0.0026	0.0026	CcSEcCtD
Nitisinone—Diarrhoea—Captopril—systemic scleroderma	0.00258	0.00258	CcSEcCtD
Nitisinone—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.00257	0.00257	CcSEcCtD
Nitisinone—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00254	0.00254	CcSEcCtD
Nitisinone—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.00249	0.00249	CcSEcCtD
Nitisinone—Abdominal pain—Leflunomide—systemic scleroderma	0.00246	0.00246	CcSEcCtD
Nitisinone—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00243	0.00243	CcSEcCtD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.00243	0.00243	CcSEcCtD
Nitisinone—Somnolence—Lisinopril—systemic scleroderma	0.00238	0.00238	CcSEcCtD
Nitisinone—Headache—Captopril—systemic scleroderma	0.00236	0.00236	CcSEcCtD
Nitisinone—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00235	0.00235	CcSEcCtD
Nitisinone—Infection—Mycophenolate mofetil—systemic scleroderma	0.00233	0.00233	CcSEcCtD
Nitisinone—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00229	0.00229	CcSEcCtD
Nitisinone—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.00228	0.00228	CcSEcCtD
Nitisinone—Diarrhoea—Azathioprine—systemic scleroderma	0.00225	0.00225	CcSEcCtD
Nitisinone—Haemoglobin—Prednisone—systemic scleroderma	0.00225	0.00225	CcSEcCtD
Nitisinone—Haemorrhage—Prednisone—systemic scleroderma	0.00223	0.00223	CcSEcCtD
Nitisinone—Pruritus—Leflunomide—systemic scleroderma	0.0022	0.0022	CcSEcCtD
Nitisinone—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00219	0.00219	CcSEcCtD
Nitisinone—Diarrhoea—Leflunomide—systemic scleroderma	0.00213	0.00213	CcSEcCtD
Nitisinone—Abdominal pain—Lisinopril—systemic scleroderma	0.00211	0.00211	CcSEcCtD
Nitisinone—Pruritus—Mycophenolic acid—systemic scleroderma	0.0021	0.0021	CcSEcCtD
Nitisinone—Eye disorder—Prednisone—systemic scleroderma	0.00209	0.00209	CcSEcCtD
Nitisinone—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.00208	0.00208	CcSEcCtD
Nitisinone—Headache—Azathioprine—systemic scleroderma	0.00206	0.00206	CcSEcCtD
Nitisinone—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00203	0.00203	CcSEcCtD
Nitisinone—Conjunctivitis—Methotrexate—systemic scleroderma	0.00202	0.00202	CcSEcCtD
Nitisinone—Alopecia—Prednisone—systemic scleroderma	0.00197	0.00197	CcSEcCtD
Nitisinone—Epistaxis—Methotrexate—systemic scleroderma	0.00196	0.00196	CcSEcCtD
Nitisinone—Headache—Leflunomide—systemic scleroderma	0.00195	0.00195	CcSEcCtD
Nitisinone—Agranulocytosis—Methotrexate—systemic scleroderma	0.00194	0.00194	CcSEcCtD
Nitisinone—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.00192	0.00192	CcSEcCtD
Nitisinone—Pruritus—Lisinopril—systemic scleroderma	0.00189	0.00189	CcSEcCtD
Nitisinone—Haemoglobin—Methotrexate—systemic scleroderma	0.00188	0.00188	CcSEcCtD
Nitisinone—Haemorrhage—Methotrexate—systemic scleroderma	0.00187	0.00187	CcSEcCtD
Nitisinone—Headache—Mycophenolic acid—systemic scleroderma	0.00186	0.00186	CcSEcCtD
Nitisinone—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00185	0.00185	CcSEcCtD
Nitisinone—Diarrhoea—Lisinopril—systemic scleroderma	0.00183	0.00183	CcSEcCtD
Nitisinone—Agitation—Prednisone—systemic scleroderma	0.00179	0.00179	CcSEcCtD
Nitisinone—Eye disorder—Methotrexate—systemic scleroderma	0.00175	0.00175	CcSEcCtD
Nitisinone—Convulsion—Prednisone—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Nitisinone—Headache—Lisinopril—systemic scleroderma	0.00167	0.00167	CcSEcCtD
Nitisinone—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.00166	0.00166	CcSEcCtD
Nitisinone—Alopecia—Methotrexate—systemic scleroderma	0.00165	0.00165	CcSEcCtD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.00164	0.00164	CcSEcCtD
Nitisinone—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.0016	0.0016	CcSEcCtD
Nitisinone—Infection—Prednisone—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Nitisinone—Skin disorder—Prednisone—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Nitisinone—Headache—Mycophenolate mofetil—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Nitisinone—Leukopenia—Methotrexate—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Nitisinone—Convulsion—Methotrexate—systemic scleroderma	0.00141	0.00141	CcSEcCtD
Nitisinone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Nitisinone—Infection—Methotrexate—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Nitisinone—Thrombocytopenia—Methotrexate—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Nitisinone—Gastrointestinal pain—Prednisone—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Nitisinone—Skin disorder—Methotrexate—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Nitisinone—Abdominal pain—Prednisone—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Nitisinone—Somnolence—Methotrexate—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Nitisinone—Pruritus—Prednisone—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Nitisinone—Diarrhoea—Prednisone—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Nitisinone—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Nitisinone—Abdominal pain—Methotrexate—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Nitisinone—Headache—Prednisone—systemic scleroderma	0.000995	0.000995	CcSEcCtD
Nitisinone—Pruritus—Methotrexate—systemic scleroderma	0.000939	0.000939	CcSEcCtD
Nitisinone—Diarrhoea—Methotrexate—systemic scleroderma	0.000908	0.000908	CcSEcCtD
Nitisinone—Headache—Methotrexate—systemic scleroderma	0.000831	0.000831	CcSEcCtD
